Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 3, 2005
Moderate glucose deprivation preconditions myocardium against infarctionD Ebel, S Redler, B Preckel, et al.
Clinical and Experimental Dermatology|January 9, 2010
Identification of a U2HR gene mutation in Turkish families with Marie Unna hereditary hypotrichosisS Düzenli, S Redler, M Müller, et al.
Clinical and Experimental Dermatology|March 27, 2015
A novel KRT86 mutation in a Turkish family with monilethrix, and identification of maternal mosaicismS Redler, S M Pasternack, S Wolf, et al.
The British Journal of Dermatology|November 26, 2018
Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinomaH M Surowy, A K Giesen, J Otte, et al.
The British Journal of Dermatology|November 22, 2007
The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areataR C Betz, K König, A Flaquer, et al.
The British Journal of Dermatology|August 18, 2012
Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severe alopecia areataS Redler, F Albert, F F Brockschmidt, et al.
The British Journal of Dermatology|December 25, 2009
The TRAF1/C5 locus confers risk for familial and severe alopecia areataS Redler, F F Brockschmidt, L Forstbauer, et al.
The British Journal of Dermatology|February 8, 2012
Investigation of the male pattern baldness major genetic susceptibility loci AR/EDA2R and 20p11 in female pattern hair lossS Redler, F F Brockschmidt, R Tazi-Ahnini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 25, 2023
Exploring the overlap between alopecia areata and major depressive disorder: Epidemiological and genetic perspectivesJ C Foo, S Redler, A J Forstner, et al.
The British Journal of Dermatology|June 29, 2021
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinomaD Westphal, M Garzarolli, M Sergon, et al.
Pageof 1